Ubs Group Ag Ginkgo Bioworks Holdings, Inc. Transaction History

Ubs Group Ag

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.28 - $1.16 $38,640 - $160,082	-138,002 Reduced 22.6%	472,595 $155,000
Q1 2024 May 13, 2024	BUY	$1.06 - $1.67 $412,323 - $649,603	388,984 Added 175.52%	610,597 $708,000
Q4 2023 Feb 09, 2024	SELL	$1.26 - $1.79 $231,128 - $328,348	-183,435 Reduced 45.29%	221,613 $374,000
Q3 2023 Nov 09, 2023	BUY	$1.61 - $2.54 $236,925 - $373,783	147,159 Added 57.06%	405,048 $733,000
Q2 2023 Aug 11, 2023	BUY	$1.14 - $1.95 $69,160 - $118,300	60,667 Added 30.76%	257,889 $479,000
Q1 2023 May 12, 2023	SELL	$1.2 - $2.19 $161,508 - $294,752	-134,590 Reduced 40.56%	197,222 $262,000
Q4 2022 Feb 08, 2023	BUY	$1.63 - $3.52 $41,439 - $89,488	25,423 Added 8.3%	331,812 $560,000
Q3 2022 Nov 10, 2022	BUY	$0.73 - $3.74 $176,481 - $904,163	241,755 Added 374.04%	306,389 $956,000
Q2 2022 Aug 10, 2022	SELL	$2.2 - $4.2 $82,022 - $156,588	-37,283 Reduced 36.58%	64,634 $154,000
Q1 2022 May 16, 2022	BUY	$2.83 - $8.69 $281,197 - $863,464	99,363 Added 3890.49%	101,917 $411,000
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $5,941 - $10,667	715 Added 38.88%	2,554 $21,000
Q3 2021 Nov 15, 2021	BUY	$9.15 - $13.28 $16,826 - $24,421	1,839 New	1,839 $21,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.